# reload+after+2024-01-23 09:43:31.161107
address1§7555 Innovation Way
city§Mason
state§OH
zip§45040
country§United States
phone§513 755 4100
fax§513 755 4567
website§https://www.atricure.com
industry§Medical Instruments & Supplies
sector§Healthcare
longBusinessSummary§AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and the Coolrail device, which enable users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Guided Coagulation System, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure compatible with a range of anatomical shapes. In addition, the company sells Lumitip Dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.
fullTimeEmployees§1050
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Michael H. Carrel', 'age': 52, 'title': 'CEO, President & Director', 'yearBorn': 1971, 'fiscalYear': 2022, 'totalPay': 1624052, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Angela L. Wirick CPA', 'age': 45, 'title': 'Chief Financial Officer', 'yearBorn': 1978, 'fiscalYear': 2022, 'totalPay': 668625, 'exercisedValue': 0, 'unexercisedValue': 137150}, {'maxAge': 1, 'name': 'Mr. Douglas J. Seith', 'age': 57, 'title': 'Chief Operating Officer', 'yearBorn': 1966, 'fiscalYear': 2022, 'totalPay': 989171, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Justin J. Noznesky', 'age': 45, 'title': 'Chief Marketing & Strategy Officer', 'yearBorn': 1978, 'fiscalYear': 2022, 'totalPay': 644729, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Deborah  Yount', 'age': 57, 'title': 'Chief Human Resources Officer', 'yearBorn': 1966, 'fiscalYear': 2022, 'totalPay': 498361, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Salvatore  Privitera J.D.', 'age': 56, 'title': 'Chief Technical Officer', 'yearBorn': 1967, 'fiscalYear': 2022, 'totalPay': 471148, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Vinayak  Doraiswamy Ph.D.', 'age': 51, 'title': 'Chief Scientific Officer', 'yearBorn': 1972, 'fiscalYear': 2022, 'totalPay': 777660, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Karl S. Dahlquist CCEP, J.D.', 'age': 53, 'title': 'Chief Legal Officer', 'yearBorn': 1970, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Valerie  Storch-Willhaus', 'title': 'Vice President of Corporate Marketing & Communications', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§5
boardRisk§1
compensationRisk§3
shareHolderRightsRisk§3
overallRisk§2
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§1.364
priceToSalesTrailing12Months§4.111733
currency§USD
dateShortInterest§1702598400
forwardEps§-0.68
pegRatio§-2.22
exchange§NGM
quoteType§EQUITY
shortName§AtriCure, Inc.
longName§AtriCure, Inc.
firstTradeDateEpochUtc§1123248600
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§03c18d5f-d166-3e68-a33f-118b1b088dc1
gmtOffSetMilliseconds§-18000000
targetHighPrice§65.0
targetLowPrice§44.0
targetMeanPrice§55.0
targetMedianPrice§53.0
recommendationMean§1.9
recommendationKey§buy
numberOfAnalystOpinions§8
quickRatio§2.236
grossMargins§0.75031996
ebitdaMargins§-0.02258
trailingPegRatio§None
